Literature DB >> 1158029

Effect of glucose on the growth hormone response to L-dopa in normal and diabetic subjects.

K Ajlouni, D R Martinson, T C Hagen.   

Abstract

The effect of hyperglycemia on the growth hormone response to oral L-dopa (500 mg.) was assessed in eight normal and eight insulin-dependent diabetic subjects. A peak growth hormone response of 21.0 +/- 4.0 ng./ml. (mean +/- S.E.M.), significantly above baseline (p less than 0.01), was achieved in the normal group following oral L-dopa. Glucose concentrations did not change and were approximately 80 mg./100 ml. throughout. Administration of 100 gm. oral glucose with the L-dopa, or thirty minutes thereafter, totally suppressed the growth hormone response in all eight and six of the subjects, respectively. A peak growth hormone response of 20.0 "/- 1.7 ng./ml. (mean +/- S.E.M.), significantly above baseline (p less than 0.001), was obtained in eight nonobese, insulin-dependent diabetics, in spite of prevailing hyperglycemia (mean plasma glucose 243-258 mg./100 ml.) throughout the test. Endogenous hyperglycemia was achieved in these patients by lessening the usual strict adherence to plasma glucose control for the purpose of the study. These results suggest an abnormality in the hypothalamus or pituitary of diabetic subjects allowing growth hormone responsiveness in spite of hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1158029     DOI: 10.2337/diab.24.7.633

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Growth hormone response to L-dopa in diabetes mellitus.

Authors:  V Sekhuja; G K Rastogi; R Sialy
Journal:  Acta Diabetol Lat       Date:  1976 Sep-Dec

2.  Diabetes self-care management practices among insulin-taking patients.

Authors:  Besher Gharaibeh; Loai Issa Tawalbeh
Journal:  J Res Nurs       Date:  2018-07-23

Review 3.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

4.  Effect of hyperglycemia on the growth hormone response to L-dopa in diabetic subjects.

Authors:  A Barbarino; L De Marinis; F Martino
Journal:  J Endocrinol Invest       Date:  1978-07       Impact factor: 4.256

5.  The response of growth hormone and prolactin to oral diazepam in diabetics.

Authors:  K Ajlouni; M El-Khateeb; M M El-Zaheri; A El-Najdawi
Journal:  J Endocrinol Invest       Date:  1982 May-Jun       Impact factor: 4.256

6.  Effect of streptozotocin diabetes and insulin replacement on growth hormone in rats.

Authors:  C Gonzalez; T Jolin
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.